Скачать или смотреть Adverum Biotechnologies

Amber Salzman, Ph.D., President and CEO
Menlo Park, CA
(NASDAQ: ADVM)

Adverum Biotechnologies is a gene therapy company committed to discovering and developing novel medicines that can offer life-changing benefits to patients living with rare diseases or diseases of the eye who currently have limited or burdensome treatment options. Adverum has a robust pipeline and is leveraging its next generation adeno-associated virus (AAV)-based directed evolution platform to generate product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company’s focus on the patient is supported by clinical development expertise and core capabilities in vector optimization, process development, manufacturing and assay development. www.adverum.com